Mycotopia Therapies Partners with Public Policy Specialist

MIAMI, May 02, 2022 (GLOBE NEWSWIRE) — Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics, announced today a partnership with Brussels-based PsychedelicsEUROPE. Mycotopia Therapies will collaborate with PsychedelicsEUROPE to accelerate its psychedelic research and develop new modelsContinue Reading

Sudden Surge in Demand for Improved Food Safety and Traceability to Open New Avenues for Development

Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) — The “Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies” report has been added to ResearchAndMarkets.com’s offering. The publisher’s research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGTContinue Reading

2021 Insights on Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies - ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies” report has been added to ResearchAndMarkets.com’s offering. The publisher’s research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, thereContinue Reading

GreenLight Biosciences Announces Business Agreement With Environmental Impact Acquisition Corp. to Become Publicly Traded Company, Allowing It to Better Harness Its Breakthrough Platform to Develop and Produce RNA for Human Therapies and Agriculture | DNA RNA and Cells

GreenLight Biosciences Announces Business Agreement With Environmental Impact Acquisition Corp. to Become Publicly Traded Company, Allowing It to Better Harness Its Breakthrough Platform to Develop and Produce RNA for Human Therapies and Agriculture Details Category: DNA RNA and Cells Published on Wednesday, 11 August 2021 18:57 Hits: 119 GreenLight Biosciences,Continue Reading

GreenLight Biosciences Announces Business Agreement With Environmental Impact Acquisition Corp. to Become Publicly Traded Company, Allowing It to Better Harness Its Breakthrough Platform to Develop and Produce RNA for Human Therapies and Agriculture

GreenLight Biosciences, Inc. to become publicly listed through business combination with Environmental Impact Acquisition Corp. (Nasdaq: ENVI) Transaction advances development of breakthrough biomanufacturing platform capable of discovering, developing, scaling, and commercializing ribonucleic acid (RNA) solutions at volume across multiple sectors in agricultural and human health markets. This combination creates aContinue Reading

Taysha Gene Therapies, MediaKind, Comerica, and More Make Moves » Dallas Innovates

Across North Texas, companies are promoting and hiring people to take on leadership positions within their organizations. Dallas Innovates covers prominent personnel moves in Dallas-Fort Worth businesses and nonprofits—from the newest startups to well-established companies. Here are the people moves tied to innovation and technology in the region. Don’t missContinue Reading